Literature DB >> 1757213

Immunosuppressive therapy in autoimmune disease--a review.

T J Counihan1, C Feighery.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1757213     DOI： 10.1007/bf02957312

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  42 in total

1.  Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis.

Authors:  P Tugwell; C Bombardier; M Gent; K J Bennett; W G Bensen; S Carette; A Chalmers; J M Esdaile; A V Klinkhoff; G R Kraag
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

2.  Successful treatment in two women with antiphospholipid antibodies and refractory pregnancy losses with intravenous immunoglobulin infusions.

Authors:  R J Wapner; F S Cowchock; S S Shapiro
Journal:  Am J Obstet Gynecol       Date:  1989-11       Impact factor: 8.661

3.  Methotrexate in rheumatoid arthritis.

Authors:  D E Furst; J M Kremer
Journal:  Arthritis Rheum       Date:  1988-03

4.  Apheresis. Biotechnology and the rheumatic diseases.

Authors:  J H Klippel
Journal:  Arthritis Rheum       Date:  1984-10

Review 5.  Methotrexate therapy in the treatment of rheumatoid arthritis.

Authors:  J M Kremer
Journal:  Rheum Dis Clin North Am       Date:  1989-08       Impact factor: 2.670

6.  Hydroxychloroquine sulphate in the treatment of rheumatoid arthritis: a double blind comparison of two dose regimens.

Authors:  K Pavelka; K P Sen; Z Pelísková; J Vácha; K Trnavský
Journal:  Ann Rheum Dis       Date:  1989-07       Impact factor: 19.103

7.  Cyclosporine improves psoriasis in a double-blind study.

Authors:  C N Ellis; D C Gorsulowsky; T A Hamilton; J K Billings; M D Brown; J T Headington; K D Cooper; O Baadsgaard; E A Duell; T M Annesley
Journal:  JAMA       Date:  1986-12-12       Impact factor: 56.272

Review 8.  Glucocorticosteroid therapy: mechanisms of action and clinical considerations.

Authors:  A S Fauci; D C Dale; J E Balow
Journal:  Ann Intern Med       Date:  1976-03       Impact factor: 25.391

9.  Intractable rheumatoid arthritis. Treatment with combined cyclophosphamide, azathioprine, and hydroxychloroquine.

Authors:  D J McCarty; G F Carrera
Journal:  JAMA       Date:  1982-10-08       Impact factor: 56.272

10.  Factors associated with early remission of type I diabetes in children treated with cyclosporine.

Authors:  P F Bougneres; J C Carel; L Castano; C Boitard; J P Gardin; P Landais; J Hors; M J Mihatsch; M Paillard; J L Chaussain
Journal:  N Engl J Med       Date:  1988-03-17       Impact factor: 91.245
View more
  1 in total

1.  Candidate SNP Markers of Gender-Biased Autoimmune Complications of Monogenic Diseases Are Predicted by a Significant Change in the Affinity of TATA-Binding Protein for Human Gene Promoters.

Authors:  Mikhail P Ponomarenko; Olga Arkova; Dmitry Rasskazov; Petr Ponomarenko; Ludmila Savinkova; Nikolay Kolchanov
Journal:  Front Immunol       Date:  2016-04-04       Impact factor: 7.561
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.